Next Article in Journal / Special Issue
Effect of Etanercept on Plasmodium yoelii MDR-Induced Liver Lipid Infiltration
Previous Article in Journal / Special Issue
Macrophage Delivered HSV1716 Is Active against Triple Negative Breast Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Preventing Microbial Infections with Natural Phenolic Compounds

1
3B’s Research Group, I3Bs–Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Guimarães, Portugal
2
ICVS/3B’s PT Government Associated Laboratory, 4805-017 Guimarães, Portugal
*
Author to whom correspondence should be addressed.
Future Pharmacol. 2022, 2(4), 460-498; https://doi.org/10.3390/futurepharmacol2040030
Submission received: 23 September 2022 / Revised: 22 October 2022 / Accepted: 31 October 2022 / Published: 2 November 2022
(This article belongs to the Special Issue Feature Papers in Future Pharmacology)

Abstract

The struggle between humans and pathogens has taken and is continuing to take countless lives every year. As the misusage of conventional antibiotics increases, the complexity associated with the resistance mechanisms of pathogens has been evolving into gradually more clever mechanisms, diminishing the effectiveness of antibiotics. Hence, there is a growing interest in discovering novel and reliable therapeutics able to struggle with the infection, circumvent the resistance and defend the natural microbiome. In this regard, nature-derived phenolic compounds are gaining considerable attention due to their potential safety and therapeutic effect. Phenolic compounds comprise numerous and widely distributed groups with different biological activities attributed mainly to their structure. Investigations have revealed that phenolic compounds from natural sources exhibit potent antimicrobial activity against various clinically relevant pathogens associated with microbial infection and sensitize multi-drug resistance strains to bactericidal or bacteriostatic antibiotics. This review outlines the current knowledge about the antimicrobial activity of phenolic compounds from various natural sources, with a particular focus on the structure-activity relationship and mechanisms of actions of each class of natural phenolic compounds, including simple phenols, phenolic acids, coumarin, flavonoids, tannins, stilbenes, lignans, quinones, and curcuminoids.
Keywords: microbiota; multidrug resistance; alternative therapeutics; natural compounds; phenolic compounds; structure-function microbiota; multidrug resistance; alternative therapeutics; natural compounds; phenolic compounds; structure-function
Graphical Abstract

Share and Cite

MDPI and ACS Style

Ecevit, K.; Barros, A.A.; Silva, J.M.; Reis, R.L. Preventing Microbial Infections with Natural Phenolic Compounds. Future Pharmacol. 2022, 2, 460-498. https://doi.org/10.3390/futurepharmacol2040030

AMA Style

Ecevit K, Barros AA, Silva JM, Reis RL. Preventing Microbial Infections with Natural Phenolic Compounds. Future Pharmacology. 2022; 2(4):460-498. https://doi.org/10.3390/futurepharmacol2040030

Chicago/Turabian Style

Ecevit, Kardelen, Alexandre A. Barros, Joana M. Silva, and Rui L. Reis. 2022. "Preventing Microbial Infections with Natural Phenolic Compounds" Future Pharmacology 2, no. 4: 460-498. https://doi.org/10.3390/futurepharmacol2040030

APA Style

Ecevit, K., Barros, A. A., Silva, J. M., & Reis, R. L. (2022). Preventing Microbial Infections with Natural Phenolic Compounds. Future Pharmacology, 2(4), 460-498. https://doi.org/10.3390/futurepharmacol2040030

Article Metrics

Back to TopTop